Published in:
Open Access
01-12-2018 | Research article
Biologic treatment of Japanese patients with inflammatory bowel disease
Authors:
Jörg Mahlich, Katsuyoshi Matsuoka, Rosarin Sruamsiri
Published in:
BMC Gastroenterology
|
Issue 1/2018
Login to get access
Abstract
Background
There is little information regarding the use of biologics in Inflammatory Bowel Disease (IBD) patients in Japan. The aim of this study was to determine the factors associated with the use of biologics in the treatment of Japanese patients with IBD.
Methods
An online survey was conducted among Japanese patients with IBD (n = 1035). Socioeconomic as well as treatment related information was collected. Logistic regression was applied to analyze the determinants of biologic treatment.
Results
Younger age (≤ 40 years vs. > 65 years; OR:0.24), time since diagnosis (< 2 years vs. < 15 years; OR: 4.16), surgical history (OR:1.98) and visiting university hospitals (university hospitals vs. clinics; OR: 0.47) were associated with biologic treatment for Japanese IBD patients.
Conclusions
Currently, biologics have been used in younger IBD patients which may give rise to the presence of an age bias in biologic treatment. Further studies are required to confirm these results and to define appropriate IBD patients who should be treated with biologic agent.